We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Hemosonics - A Stago Company

HemoSonics is a medical device company developing a point-of-care diagnostic platform to guide the management of crit... read more Featured Products: More products

Download Mobile App




Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

By LabMedica International staff writers
Posted on 05 Apr 2024

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. More...

These transfusions, while critical, are linked to various adverse clinical outcomes, including the need for reoperations due to bleeding. Current treatment options for coagulopathic bleeding include a range of allogeneic blood components and pharmacological agents, but their effective application depends upon the availability of accurate and prompt diagnostic tests. These tests are essential for selecting the appropriate treatment needs, thereby curtailing unnecessary transfusions, minimizing waste of blood products, cutting healthcare costs, and ultimately enhancing patient care. Implementing patient blood management strategies plays a pivotal role in maintaining hemostasis, reducing bleeding, and lowering the transfusion requirement. Now, a cartridge-based device with unique ultrasound technology that can measure the viscoelastic properties of whole blood during coagulation provides comprehensive blood analysis, helping clinicians manage patients back into hemostasis.

The Quantra hemostasis analyzer from HemoSonics (Durham, NC, USA), part of the Stago Group, empowers healthcare professionals to make individualized, evidence-driven decisions on managing bleeding patients, ensuring that the administered treatments are suitable and in line with global initiatives to reduce inappropriate transfusions of blood products. The Quantra hemostasis system, comprising the Quantra hemostasis analyzer along with the QPlus and QStat cartridges, facilitates decision-making on bleeding management, thereby elevating patient care and enhancing the efficiency of blood product utilization. Designed for ease of maintenance and simple operation and interpretation, the Quantra System delivers rapid, in-depth whole-blood coagulation assessments either at the point of care or in lab settings, producing results in under 15 minutes.

Granted clearance by the U.S. Food and Drug Administration (FDA) for use in critical care settings, including operating rooms, ICUs, and hospital labs, the Quantra system enables hospitals to standardize use institution-wide with higher operational efficiency. The QStat cartridge for use with the Quantra hemostasis analyzer was first approved by the FDA in 2022 for processing venous whole blood samples. HemoSonics has now been granted Special 510(k) clearance by the FDA for the expanded use of arterial blood samples with its Quantra QStat cartridge, allowing hospitals to further standardize and operationalize viscoelastic testing with an arterial and venous indication for both HemoSonics' QStat Cartridge and the QPlus cartridges.

"The FDA 510(k) clearance for arterial blood sample use with our QStat Cartridge will make it easier and more convenient for hospitals to use the Quantra System," said Bob Roda, President and CEO of HemoSonics. "The Quantra System now has the broadest range of FDA-cleared clinical indications of any cartridge-based viscoelastic testing system. It is cleared for use in cardiac, trauma, liver, and major orthopedic surgeries. We will continue to innovate in our mission to help patients and hospitals preserve blood, which is a precious resource."


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.